Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ammonium ions (NH4+) are positively charged polyatomic ions produced primarily through the catabolism of amino acids and the action of urease-producing bacteria in the gastrointestinal tract (StatPearls, NBK557504). In healthy individuals, the liver efficiently converts ammonia into urea via the urea cycle for renal excretion (PubChem, CID 223). However, in conditions such as liver failure or urea cycle disorders, ammonium ions accumulate in the blood, leading to hyperammonemia. These ions are highly neurotoxic as they can cross the blood-brain barrier, causing astrocyte swelling and cerebral edema, which manifests clinically as hepatic encephalopathy (PubMed, 28839332). Therapeutic interventions target ammonium ions by either reducing their production in the gut using antibiotics like Rifaximin and osmotic laxatives like Lactulose, or by enhancing their clearance through nitrogen-scavenging agents like Sodium phenylbutyrate (LiverTox, NBK548258). Lactulose specifically works by acidifying the colonic environment, which converts ammonia (NH3) into the non-absorbable ammonium ion (NH4+), effectively trapping it for fecal excretion. Scavenging drugs provide alternative metabolic pathways by conjugating with amino acids like glutamine or glycine to form excretable products (StatPearls, NBK557504). Monitoring blood levels of these ions is essential for managing patients with acute or chronic liver disease and inherited metabolic defects.
Reduction of ammonia production by gut flora, acidification of the colon to trap ammonium ions, and pharmacological scavenging of nitrogen via alternative metabolic pathways for excretion.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonium ion (NH4+) (NH4+).